ArticleLancet regional health. Americas2026
Assessing methodological differences in estimating exposure to intimate-partner violence against women in Brazil: a multi-source observational analysis.
Article in Lancet regional health. Americas, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Background: Intimate partner violence (IPV) is a global public health issue. However, prevalence estimates vary depending on the data source and methodology used. This study aimed to assess methodological differences in estimating the prevalence and age distribution of physical and sexual IPV across multiple Brazilian data sources. Methods: We assessed and analyzed seven Brazilian data sources: five surveys and two administrative datasets. Surveys used either the World Health Organization (WHO) instrument on violence against women and adaptations or an adapted version of the Revised Conflict Tactics Scales. The analysis included only women aged 16 years or older, and race was not examined. Recall periods varied from 12 to 24 months. We estimated prevalence and age distribution of physical and sexual IPV with 95% confidence intervals (CIs). Findings: The seven sources represented national, regional, and local populations. Methodological differences, including questionnaires, interview settings, data collection methods, and recall periods, may explain variation across data sources. Among national-level estimates, physical IPV prevalence ranged from 0.4% (0.3-0.7) to 13.0% (8.3-17.8) across data sources and age strata, with all sources consistently showing higher prevalence and proportions among younger women. For sexual IPV, no age group pattern emerged in prevalence or proportions. Interpretation: This study revealed substantial heterogeneity in estimates of IPV prevalence and age distribution. Without a gold standard for IPV measurement, these findings underscore the need to interpret available estimates in light of the methodological context in which they were generated. Funding: The Gates Foundation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.